American Journal of Psychiatry
 |
|
|
Former names
|
American Journal of Insanity |
|---|---|
|
Abbreviated title (ISO 4)
|
Am. J. Psychiatry |
| Discipline | Psychiatry |
| Language | English |
| Edited by | Robert Freedman |
| Publication details | |
| Publisher |
American Psychiatric Association (United States)
|
|
Publication history
|
1844–present |
| Frequency | Monthly |
| 12.295 | |
| Indexing | |
| ISSN |
0002-953X (print) 1535-7228 (web) |
| LCCN | 22024537 |
| CODEN | AJPSAO |
| OCLC no. | 1480183 |
| Links | |
The American Journal of Psychiatry is a monthly peer-reviewed medical journal covering all aspects of psychiatry and the official journal of the American Psychiatric Association. The first volume was issued in 1844, at which time it was known as the American Journal of Insanity. The title changed to the current form with the July issue of 1921.
The Journal regularly publishes reports of pharmaceutical industry-sponsored clinical trial results of psychiatric drugs.
According to the Journal Citation Reports, the journal has a 2016 impact factor of 13.505.
Several complaints, including legal cases, have charged the American Journal of Psychiatry with being complicit in pharmaceutical industry corruption of clinical trial results. In a Department of Justice case against Forest Pharmaceuticals, Forest pled guilty to the charges of misbranding the drug Celexa (citalopram). The Complaint in Intervention clearly identifies a 2004 ghostwritten article published in the American Journal of Psychiatry in the names of Wagner et al as a part of this illegal marketing of Celexa for pediatric depression.
...
Wikipedia